Trial Profile
Effect of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin on Forearm Endothelial Function in Diabetics
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 30 May 2016 New trial record